Yahoo Finance 
Insights on the Brain Cancer Therapeutics Global Market to 2028 - Featuring Amgen, AstraZeneca and F. Hoffmann-La Roche Among Others
Brain Cancer Therapeutics Market
Dublin, April 29, 2022 (GLOBE NEWSWIRE) -- The "The Brain Cancer Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
Cancer is one of the most prevalent and fatal chronic disorders with a high mortality rate. Throughout our lives, healthy cells in our bodies divide and replace themselves in a controlled fashion. Cancer starts when a cell is altered and it multiplies out of control. A tumor is formed when such abnormal cells grow to form a mass. Cancer cells grow to form tumor that interfere with brain functions such as muscle control, memory, sensation, and other normal bodily functions. Symptoms of brain cancer vary but often include weakness, difficulty walking, dizziness, seizures, and headaches.
The brain and spinal column make up the central nervous system (CNS), where all important functions are controlled. These functions include thought, body movements, and speech. This means that when a tumor grows in the CNS, it can affect a person's thought processes or the way they move or talk. A treatment plan is individualized and planned for each brain cancer patient depending on certain factors. The treatment plan is constructed by the doctors who are specialized in brain cancer, and treatments vary widely depending on the type of cancer, brain location of the tumor, tumor size, patient age, and the general health status of the patient. A major part of the plan is also determined by the wish of the patient.
Market Dynamics
The increasing launches of new drugs and regulatory approvals for brain cancer therapeutics are expected to drive the market growth during the forecast period. For instance, in June 2020, Food and Drug Administration (FDA) has granted fast track designation to TVAX Biomedical, Inc. for TVI-Brain-1, an adoptive T cell therapy for the treatment of glioblastoma multiforme. TVI-Brain-1 (TVAX Biomedical) is an autologous, vaccine-enhanced adoptive T-cell therapy consisting a proprietary vaccine pretreatment to create cancer-specific T cells and an activated antitumor T-cell treatment. The Fast Track Designation was supported by positive Phase 2 clinical data in addition to extensive preclinical and Phase 1 safety studies.
Key features of the study:
This report provides an in-depth analysis of the global brain cancer therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global brain cancer therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Johnson & Johnson, Merck & Co, Bayer AG, and Bristol-Myers Squibb Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global brain cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brain cancer therapeutics market
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunity
Impact Analysis
Pipeline Analysis
Regulatory Scenario
Market Trends
Key Developments
Epidemiology
PEST Analysis
Brand Analysis
4. Global Brain Cancer Therapeutics Market- Impact of Coronavirus (COVID-19) Pandemic
Economic Impact
Impact on Clinical Trials and Drug Development
Government Initiatives
5. Global Brain Cancer Therapeutics Market, By Indication, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Glioblastoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Meningioma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Pituitary Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Brain Cancer Therapeutics Market, By Treatment Type, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Targeted Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Brain Cancer Therapeutics Market, By Distribution Channel, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Brain Cancer Therapeutics Market, By Region, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2021 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2017-2028
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Region/Countries, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Amgen Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
For more information about this report visit https://www.researchandmarkets.com/r/7y9h8h
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
